TEO SOLEYMANI: Open Payments
NPI 1447679865 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,443 in 51 payments from 14 companies in 2025. Trend: 2023 $143 · 2024 $310 · 2025 $17,443
Consulting: $13,764Travel & lodging: $2,196Food & beverage: $1,483
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $16,235 |
| ABBVIE INC. | 13 | $267 |
| Organogenesis Inc. | 2 | $205 |
| GENZYME CORPORATION | 4 | $176 |
| UCB, Inc. | 5 | $158 |
| Incyte Corporation | 4 | $94 |
| KYOWA KIRIN, INC. | 2 | $59 |
| LEO Pharma Inc. | 2 | $52 |
| Janssen Biotech, Inc. | 2 | $46 |
| Arcutis Biotherapeutics, Inc. | 2 | $44 |
Products named: LIBTAYO, BOTOX, CYGNUS DUAL, DUPIXENT, Bimzelx, OPZELURA, POTELIGEO, ADBRY.
Industry payments across CA — which companies pay providers there.
